Lifecore Biomedical to Be Acquired by Webster Equity Partners

Attorneys from Ballard Spahr's Corporate and Mergers and Acquisitions Groups represented Lifecore Biomedical, a fully-integrated contract development and manufacturing organization specializing in the development, fill/finish, and commercialization of sterile injectable drugs, biologics, medical devices, and combination products, in its acquisition by Webster Equity Partners.

A team led by April Hamlin, Brian D. Short, Barbara Lano Rummel, Harry A. Levin, and Kyra Honkanen advised Lifecore Biomedical and its Board of Directors in the transaction.

Read the full article here. (Subscription may be required.)